Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-698-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- GLP guideline study tested with the source substance D-Glucopyranose, oligomers, hexyl glycosides. According to the ECHA guidance document “Practical guide 6: How to report read-across and categories (March 2010)”, the reliability was changed from RL1 to RL2 to reflect the fact that this study was conducted on a read-across substance.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 998
- Report date:
- 1998
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 84-2
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- THE DEPARTEMENT OF HEALTH OF THE GOVERNMENT OF THE UNITED KINGDOM
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Glucopyranose, oligomers, hexyl glycosides
- IUPAC Name:
- Glucopyranose, oligomers, hexyl glycosides
- Details on test material:
- - Name of test material (as cited in the study report): trade name
- Physical state: amber viscous liquid
- Analytical purity: 75%
- Lot/Batch number: P8030
- Storage conditions: room temperature in the dark
Constituent 1
Method
- Target gene:
- his operon (S. typhimurium) and trp operon (E. coli)
Species / strain
- Species / strain / cell type:
- other: S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2uvrA
- Details on mammalian cell type (if applicable):
- - Type and identity of media: nutrient broth (Oxoid Limited)
- Properly maintained: yes
- Periodically checked for karyotype stability: yes
- Periodically "cleansed" against high spontaneous background: yes
- Metabolic activation:
- with and without
- Metabolic activation system:
- co-factor supplemented post-mitochondrial fraction (S9-mix), prepared from the livers of male Sprague Dawley rats induced with Aroclor 1254 (single i.p. injection of 500 mg/kg bw)
- Test concentrations with justification for top dose:
- Range finding study: 0, 0.1 5, 0.5, 1.5, 5, 15, 50, 150, 500, 1500 and 5000 µg/plate
Main study (Experiment I and II): 0, 50, 150, 500, 1500 and 5000 µg/plate - Vehicle / solvent:
- - Vehicle/solvent used: DMSO
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: ENNG (-S9; 2-5 µg/plate; TA100, TA1535, WP2 uvrA); 9-AA (-S9; 80 µg/plate; TA1537); 4-NQO (-S9; 0.2 µg/plate; TA 98); 2-AA (+S9; 1-10 µg/plate; TA 100, TA 1535, TA 1537, WP2 uvrA); BP (+S9; 5 µg/plate; TA 98)
- Remarks:
- N-ethyl-N'-nitro-N-nitrosoguanidine (ENNG); 9-Aminoacridine (9AA); 4-Nitroquinoline-1-oxide (4NQO); 2 -Aminoanthracene (2AA); Benzo(a)pyrene (BP)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: plate incorporation
DURATION
- Exposure duration: 48 h
NUMBER OF REPLICATIONS: triplicate
NUMBER OF CELLS EVALUATED: not applicable; total frequency of revertant colonies assessed
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth, reduction of the bacterial background lawn, other: frequency of revertant colonies assessed using a Domino colony counter - Evaluation criteria:
- The test material was considered to be positive in this test system if the following criteria were met:
- the test was valid (see criteria below)
- test material induced a reproducible, dose-related and statistically (Dunnett's method of linear regression) significant increase in the revertant count in at least one strain of bacteria.
- a greater than 2-fold increase in revertant count was observed in two experiments.
Acceptance Criteria: the reverse mutation assay was considered valid if the following criteria were met:
- all tester strain cultures exhibited a characteristic number of spontaneous revertants per plate in the vehicle and untreated controls which was within the historical control range
- the appropriate characteristics for each tester strain were confirmed, e.g. rfa cell-wall mutation and pkM101 plasmid R-factor etc.
- all tester strain cultures were in the range of 1 to 9.9 x 10E+9 bacteria per mL
- each mean positive control value was at least two times the respective vehicle control value for each strain, thus demonstrating both the intrinsic sensitivity of the tester strains to mutagenic exposure and the integrity of the S9-mix.
- a minimum of 4 non-toxic dose levels was achieved and
- no evidence of excessive contamination was observed. - Statistics:
- Mean values and standard deviation were calculated for the number of revertants of each group. Statistical analysis was performed using the Dunnett's method of linear regression.
Results and discussion
Test results
- Species / strain:
- other: S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2uvrA
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RANGE-FINDING/SCREENING STUDIES:
The dose range of the test material used in the preliminary toxicity study was 0, 0.1 5, 0.5, 1.5, 5, 15, 50, 150, 500, 1500 and 5000 µg/plate. The test
material was non-toxic to the strains of bacteria used (TA100 and WP2uvrA).
COMPARISON WITH HISTORICAL CONTROL DATA:
Vehicle and positive control values were within historical control values. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Table 1. Maximum number of revertants (Mean ± SD)
Plate incorporation assay (Experiment I: 0, 50, 150, 500, 1500 and 5000 µg/plate) |
||||||
|
-S9 |
+S9 |
||||
Strain |
Control (DMSO) |
Test compound (µg/plate) |
Positive controls |
Control (DMSO) |
Test compound (µg/plate) |
Positive controls |
TA 100 |
108 ± 8 |
116 ± 2 (5000) |
785 ± 40 |
120 ± 7 |
133 ± 6 (150) |
1117 ± 113 |
TA 1535 |
35 ± 2 |
34 ± 3 (5000) |
247 ± 34 |
18 ± 6 |
24 ± 3 (1500) |
258 ± 2 |
WP2 uvrA |
28 ± 2 |
29 ± 2 (150) |
781 ± 39 |
36 ± 5 |
32 ± 3 (150) |
1203 ± 17 |
TA 98 |
38 ± 6 |
40 ± 4 (50) |
130 ± 15 |
50 ± 4 |
51 ± 4 (1500) |
540 ± 186 |
TA 1537 |
6 ± 2 |
9 ± 2 (1500) |
1112 ± 98 |
13 ± 3 |
14 ± 1 (150) |
286 ± 40 |
Plate incorporation assay (Experiment II: 0, 50, 150, 500, 1500 and 5000 µg/plate) |
||||||
|
-S9 |
+S9 |
||||
Strain |
Control (DMSO) |
Test compound (µg/plate) |
Positive controls |
Control (DMSO) |
Test compound (µg/plate) |
Positive controls |
TA 100 |
142 ± 5 |
151 ± 8 (500) |
530 ± 42 |
136 ± 13 |
148 ± 4 (5000) |
986 ± 117 |
TA 1535 |
27 ± 2 |
30 ± 4 (150) |
288 ± 49 |
22 ± 6 |
26 ± 4 (1500) |
285 ± 52 |
WP2 uvrA |
21 ± 6 |
27 ± 1 (5000) |
751 ± 31 |
21 ± 5 |
22 ± 4 (500) |
942 ± 64 |
TA 98 |
36 ± 6 |
38 ± 2 (150) |
122 ± 7 |
41 ± 2 |
43 ± 4 (50) |
606 ± 15 |
TA 1537 |
10 ± 2 |
12 ± 3 (1500) |
938 ± 152 |
16 ± 1 |
17 ± 1 (150) |
402 ± 21 |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.